Parnassus Investments
Parnassus Endeavor Fund
Parnassus Endeavor Fund Cigna Corp stake
total: 118
Parnassus Endeavor Fund CI trades
- Total transactions:
- 10
- New positions:
- 1
- Added:
- 7
- Reduced:
- 2
- Held since:
- 2023 Q3
- Held for:
- 12 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Parnassus Endeavor Fund holds 360,366 Cigna Corp (CI) shares with a market value of roughly $99.35M accounting for 1.88% of the overall portfolio. To date, the estimated cost basis is nearly $295.1 for "buy" trades and estimated average "sell" price is $322.46. Parnassus Endeavor Fund first purchased CI in 2023 Q3, initially acquiring 161,803 shares. Since the initial investment in Cigna Corp (CI), Parnassus Endeavor Fund has made 9 more transactions.
When did Parnassus Endeavor Fund buy Cigna Corp (CI)?
Parnassus Endeavor Fund first invested in Cigna Corp (CI) in 2023 Q3 at the reported quarter-end price of $286.07 per share.
What's the cost basis of Parnassus Endeavor Fund's CI stake?
The estimated cost basis for Cigna Corp (CI) stake is around $295.10 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $295.10
- Weighted AVG sell price:
- $322.46
Parnassus Endeavor Fund's historical trades in Cigna Corp
10 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
1.88%
|
360,366
|
$275.68
|
$99,345,699
|
+4.15% (+14,358)
|
+0.07%
|
|
2026 Q1
|
2.00%
|
346,008
|
$266.75
|
$92,297,634
|
+3.10% (+10,397)
|
+0.06%
|
|
2025 Q4
|
1.94%
|
335,611
|
$275.23
|
$92,370,216
|
+2.59% (+8,468)
|
+0.05%
|
|
2025 Q3
|
2.00%
|
327,143
|
$288.25
|
$94,298,970
|
+14.42% (+41,226)
|
+0.25%
|
|
2025 Q2
|
2.08%
|
285,917
|
$330.58
|
$94,518,442
|
+0.12% (+341)
|
+0%
|
|
2025 Q1
|
2.10%
|
285,576
|
$329.00
|
$93,954,504
|
+20.39% (+48,371)
|
+0.36%
|
|
2024 Q4
|
1.36%
|
237,205
|
$276.14
|
$65,501,789
|
-14.33% (-39,666)
|
-0.22%
|
|
2024 Q3
|
1.89%
|
276,871
|
$346.44
|
$95,919,189
|
-21.68% (-76,626)
|
-0.54%
|
|
2023 Q4
|
2.16%
|
353,497
|
$299.45
|
$105,854,677
|
+118.47% (+191,694)
|
+1.17%
|
|
2023 Q3
|
1.02%
|
161,803
|
$286.07
|
$46,286,984
|
new
|
+1.02%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.